PubMed Health⌕ Search

Biomedical subjects

D W Weiss

Publications and source records attributed to D W Weiss.

At least 73 records · Page 4Linked to original sources

Effects of methanol extraction residue and therapeutic irradiation against established isografts and simulated local recurrence of mammary carcinomas.

Female BALB/c mice carrying established isografts or simulated local recurrence implants of 2 rapidly growing mammary adenocarcinomas were treated either by injection of the methanol extraction residue (MER) fraction of killed Bacillus Calmette-Guérin organisms (given s.c. or into the tumor) or by focal X-irradiation or by both. None of the modalities of therapy effected cures, but in many instances there was a significant retardation of tumor cevelopment and prolongation of the lives of the mice. Administration of MER alone offered protection in a number of cases but less often than the other forms of treatment. Combined therapy with MER and irradiation was, on the whole, the most successful therapeutic intervention. MER or irradiation administered alone enhanced the neoplastic process only on rare occasions; this appeared to be the case even more infrequently with combined treatment. MER was most likely to be effective alone or in combination when small quantities were used and when only 1 treatment or 1 cycle of combined therapy was given. The therapeutic action of MER was not dependent on direct introduction of the agent into a neoplastic focus; s.c. administration distal to the tumor site was almost always at least as satisfactory as injection directly into the tumor mass and indeed was often more efficacious.

Adenocarcinoma↗

Cellular immunity against Rous sarcomas of chickens. Preferential reactivity against autochthonous target cells as determined by lymphocyte adherence and cytotoxicity tests in vitro.

Spleen cells from random-bred chickens bearing Rous sarcomas were commonly more reactive against the neoplastic target cells in autochthonous than in allogenic interactions in vitro. This difference was observed both in cytotoxic assays ((51)Cr release from labeled target cells) and in an immunoadherence test measuring attachment of (51)Cr-labeled splenocytes to Rous sarcoma cells. Specific splenocyte reactivity was not observed with normal embryonic chicken fibroblasts, 3T3 cells, or embryonic mouse C3H fibroblasts. The immunoadherence technique required only 2 hr to perform, and revealed a more consistent superiority of autochthonous recognition of Rous sarcoma cells than the cytotoxicity assay. Experiments in which both procedures were used simultaneously with identical cell populations yielded similar results, indicating that splenocyte adherence may be a precursor of and/or concomitant to target cell damage and that individual-specific tumor antigencity may play a part in cellular immunity against Rous sarcomas.

Animals↗